HomeStock SectorsEnergy StocksOil Prices Rebound Despite...

Oil Prices Rebound Despite OPEC+ Output Hike as Markets Rethink Supply Risk

surged yesterday after gapping down over the weekend. The gap down came about as the + group, which includes OPEC and its allies, agreed to increase oil production by 548,000 barrels per day in August.

This is a bigger rise compared to the 411,000 barrels per day added in each of the last three months.

The surprise for many is the rise in Oil since Sunday night’s market opened, and from my point of view there are two reasons for this which we will break down now.

Markets Misinterpret OPEC + Production Increase

Looking at the data and the overall Oil market at the moment, the move by OPEC + seems to be one targeted at gaining market share rather than price stability. This should be the actual talking point, as this is the real pivot being done by OPEC +.

Since the Covid-19 decline in oil prices OPEC + have constantly said that they are prioritizing price stability, however recent decisions suggest otherwise.

Despite conflicts and economic pressures, oil demand remains strong, especially in Asia and Africa. Western markets also continue to rely on oil despite the rise of EVs. Oil producers and OPEC members such as Iran are not even involved in the ongoing discussion regarding the unwinding of OPEC production quotas.

Production agreements show higher volumes, but actual output is still below those targets. Many OPEC members can’t meet their quotas, so fears of an oversupply are exaggerated.

The biggest impact will be on international oil companies, not consumers or producers. While profit margins might shrink, as Shell has warned, the situation isn’t critical. Shell’s concerns about a weak second half of 2025 shouldn’t cause alarm.

Positive signs for oil prices remain strong, including increased Houthi activity in the Red Sea, tensions with Iran, Russia’s economic struggles, and rising demand for private power generation.

Trade Deal Optimism to Keep Oil Prices Supported

Markets remain optimistic that trade deals will materialize and not have a huge impact on global growth. Whether misguided or not that is what recent price action is suggesting.

Looking at other risk assets, we are seeing a similar trend as news came through on trade deal announcements yesterday. The deadline of August 1 means the next three weeks could continue to display similar sways in price as markets digest trade deals and their potential implications.

Oil Inventories Data Ahead

The (American Petroleum Institute) stock change data will be out later today. The data represents the weekly change in U.S. crude oil inventories with markets expecting a print of -2.8M.

data will be out tomorrow as well and will provide us with more information on the total amount of crude oil stored in U.S. facilities.

Technical Analysis – WTI

From a technical standpoint, continues to exhibit bullish potential.

A trendline break which occurred around June 9 was followed by a bullish rally close to 77.70 before a pullback and retest of the trendline.

Since then Oil has consolidated and has been on a grind higher and is currently caught between the 100 and 200-day MAs.

A break above the 200-day MA could lead to further upside toward resistance around the 71.38 handle.

A break below the 64.73 handle would invalidate the current bullish narrative for me and could lead to a retest of the psychological 60.00 handle.

There is also a ascending trendline currently in play which could be a good guide as to the trend moving forward. A break of the trendline would be the first sign of caution that further downside may be incoming.

Source: TradingView.com

Support

Resistance

Original Post

Most Popular

More from Author

Illiquid, Overvalued Assets Spark Market Fears as Buyers Retreat

As "dip buyers" get eviscerated, more dominos fall, and at a...

Why Did ZyVersa Therapeutics Stock Shoot Higher On Tuesday? – ZyVersa Therapeutics (NASDAQ:ZVSA)

ZyVersa Therapeutics, Inc. ZVSA stock was trading higher on Tuesday, with a...

US Dollar Gains as Tariff Letters Erode Risk Appetite

Trump letters and August 1 deadline in focus Dollar strengthens as both...

Read Now

Illiquid, Overvalued Assets Spark Market Fears as Buyers Retreat

As "dip buyers" get eviscerated, more dominos fall, and at a tipping point, the herd realizes the tide has reversed and it’s time to sell--but alas, it’s too late. Illiquid, Overvalued describes a great many assets that are on the books as "rock-solid investments." Illiquidity...

Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks – Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)

In a significant legal challenge that could reshape the future of public health policy in the United States, a powerful alliance of leading medical and public health organizations, including the American Academy of Pediatrics (AAP), the American College of Physicians (ACP), and the American Public Health Association...

Why Did ZyVersa Therapeutics Stock Shoot Higher On Tuesday? – ZyVersa Therapeutics (NASDAQ:ZVSA)

ZyVersa Therapeutics, Inc. ZVSA stock was trading higher on Tuesday, with a session volume of 160.9 million compared to the average volume of 4.03 million as per data from Benzinga Pro.What HappenedZyVersa Therapeutics provided regulatory and product support for FDA-authorized Emergency Compassionate Use of Cholesterol Efflux Mediator VAR 200...

US Dollar Gains as Tariff Letters Erode Risk Appetite

Trump letters and August 1 deadline in focus Dollar strengthens as both China and the EU avoid tariff letters Equities are wobbly, while gold confirms lingering demand Aussie gains as RBA surprises by keeping rates unchanged Liberation Date: Version 2The approval of the US Budget Bill has allowed US President Trump...

Wall Street Is On Fire—So Why Is This Wall Of Cash Moving Abroad? – iShares Core MSCI Emerging Markets ETF (ARCA:IEMG)

U.S. stocks may be breaking records, but a flood of investor cash is moving elsewhere—toward emerging markets, where valuations are cheaper, currencies are strengthening and years of underperformance may finally be reversing.The iShares Core MSCI Emerging Markets ETF IEMG has attracted $7.4 billion in inflows so far...

Why CARGO Therapeutics Stock Is Gaining Today – Cargo Therapeutics (NASDAQ:CRGX)

CARGO Therapeutics Inc. CRGX saw its stock climb on Tuesday after the biotech firm announced a merger agreement with Concentra Biosciences LLC.Under the terms of the agreement, Concentra will acquire CARGO for $4.379 in cash per share, along with a non-transferable contingent value right.The CVR entitles shareholders...

Gold Prices Slip Amid Trump’s Tariff Delay and Fed Rate Cut Speculations

Gold Pressured by Trade Tariffs On Monday, U.S. President Donald Trump posted letters on Truth Social addressed to the leaders of 14 countries. He threatened to impose tariffs ranging from 25% to 40% on imports unless countries address trade imbalances. The letters targeted China, Germany, Japan, Mexico, and...

Artelo Biosciences Analyst See It As An Emerging Biotech – Artelo Biosciences (NASDAQ:ARTL)

D. Boral Capital upgraded Artelo Biosciences, Inc. ARTL on Tuesday.The analyst upgraded from Hold to Buy and introduced a price forecast of $20.Analyst Jason Kolbert wrote, “We continue to view Artelo as an emerging biotechnology company focused on Cachexia and chemotherapy-induced peripheral neuropathy (CIN) with the lead...

Asian Stocks Climb as Trump Signals Openness to Trade Talks Before Tariff Deadline

Asian stock markets remained steady despite the latest update on US President Donald Trump’s tariff plans. On Tuesday, the stayed strong, and dropped. In the US, stock prices fell after Trump sent letters to 14 countries, including Japan and South Korea, announcing much higher tariffs on...

Why Is Cogent Biosciences Stock Soaring On Tuesday? – Cogent Biosciences (NASDAQ:COGT)

On Monday, Cogent Biosciences, Inc. COGT said bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis.The company said that its experimental drug reduced the symptoms of a chronic immune disorder called non-advanced systemic mastocytosis.The latest study demonstrated meaningful and highly statistically significant improvements across the...

Are Markets Underpricing the Next Tariff Shock?

Economic activity appears set to strengthen in the official Q2 , but the second half of the year looks relatively vulnerable. One factor is the possibility that the simmering trade war may heat up after President Trump on Monday announced new tariffs set to begin on August...

Does Higher Dose Of Wegovy Result In More Weight Loss – Novo Nordisk (NYSE:NVO)

Novo Nordisk A/S NVO on Tuesday announced that it has submitted an application to the European Medicines Agency (EMA) for approval of a new, higher dose of its obesity treatment, Wegovy (subcutaneous semaglutide 7.2 mg).The submission is based on clinical data from the STEP UP and STEP...